There is currently no preventive measure for HCM itself, although early detection and
treatment slows the progression of the disease, hopefully sparing the patient its more serious complications, such as FATE.
While treatment doesn't cure chronic feline renal failure,
treatment slows its progression, making symptoms more manageable.
Not exact matches
Despite decades of scientific research, there is no
treatment that can
slow the
progression of Alzheimer's.
That delay followed the failure of a trial in November of Lilly's experimental Alzheimer's
treatment solanezumab, which the company had hoped would be the first medicine approved to
slow progression of the disease.
He contributes to other large - scale clinical trials including SAVE (evaluating whether
treatment of obstructive sleep apnoea with continuous positive airways pressure can reduce the incidence of serious CV events in patients with established CVD), and CREDENCE, a randomised, double - blind, placebo - controlled trial assessing whether canagliflozin can
slow the
progression of diabetic nephropathy in patients with type 2 diabetes.
There's currently no
treatment for Alzheimer's that can
slow or stop the disease's
progression, so catching it early can't currently improve a patient's outcome.
The new study, called FOR - DMD (Finding the Optimum Regimen of Corticosteroids for Duchenne Muscular Dystrophy), will determine whether daily steroid
treatment or an alternative regime is more effective in
slowing the disease
progression and managing side effects.
Next up: a larger trial in hundreds of patients to see if lowering mutant Htt protein
slows progression of the disease, then a trial in healthy people who carry the mutant HTT gene to see if antisense
treatments could prevent Huntington's altogether.
In addition to suggesting that creatine could
slow the
progression of HD, these results also imply that neuroimaging may provide a useful biomarker of disease modification in studies of other potential
treatments.
«The search for
treatments that
slow the
progression of neurodegenerative diseases has gradually shifted from ameliorating symptoms to finding agents that reduce the
progression of the disease,» said Gary Lynch, PhD, who studies neurodegeneration at the University of California, Irvine, and was not involved with this study.
A drug which has already been in use for decades to treat liver disease could be an effective
treatment to
slow down
progression of Parkinson's disease, scientists from the University of Sheffield have discovered.
Although
treatments for AIDS and HIV exist to
slow the virus's
progression, there is no known cure.
In the end, the identification of microbial species or metabolites that are altered in Parkinson's disease may serve as disease biomarkers or even drug targets, and interventions that correct microbial imbalances may provide safe and effective
treatments to
slow or halt the
progression of often debilitating motor symptoms.
«While significant effort is being put into developing
treatments to
slow or block the
progression of Alzheimer's dementia, little work has been done to get the medical system ready for such an advancement,» said Jodi Liu, lead author of the study and a policy researcher at RAND, a nonprofit research organization.
The studies not only point to the future possibility of specific microRNAs as a
treatment for colorectal cancer, but also to the importance of external metabolic events conducted outside the cancer cell in the
progression of the disease — factors that could someday be targeted to help
slow metastasis, or even block it entirely.
No existing
treatments can
slow the disease's
progression, and most victims die by midlife.
«Obviously,
treatment can
slow down the
progression.»
«This study also highlights the potential use of this anti-estrogen or miRNA in patients with recurrent prostate cancer, for whom there is no
treatment, and raises the possibility of using anti-estrogen or miRNA
treatments in preventing or
slowing progression for primary prostate cancer.»
«It is unclear whether any
treatment could
slow progression of the disease if it was recognised early.»
MEDICAL RESOURCES • The
progression of Alzheimer's disease might be
slowed down by
treatment using intravenous immunoglobulin (IVIG).
«We do not yet have
treatments that can
slow the
progression of Huntington's disease but, when we do, measuring the mutant protein in CSF could guide clinical decisions such as the best time to start a
treatment,» said Dr Douglas Macdonald at CHDI.
Current
treatments for Duchenne muscular dystrophy are limited to steroids and physical therapy that
slow disease
progression and lessen symptoms.
«There could be a significant increase in prostate cancer death rates if more people are diagnosed with metastatic disease, because
treatments can only
slow progression, it's not curable,» Schaeffer said.
If men present with metastatic prostate cancer,
treatments are not curative and only
slow disease
progression.
«We still need more studies to determine if there are other
treatments that can be used to
slow the
progression of kidney disease specifically in individuals with sickle cell trait.»
The research goal, as we are putting it out there today, is to develop an effective
treatment strategy, delay the onset and
slow the
progression of the disease.
At the moment, the only
treatments are drugs such as interferon beta - 1a and glatiramer acetate (Copaxone), both of which merely
slow the
progression of the disease.
New research findings indicate that an early onset of dietary
treatment may
slow down the
progression of Alzheimer's disease.
In the drug trial, researchers have shown that
treatment with a type of sugar molecule called cyclodextrin
slows progression of the disease.
Alzheimer's disease is the most common dementia type, with no
treatment to
slow down the
progression of the disease currently available.
Current rheumatoid arthritis
treatments focus on intercepting the immune system's misdirected attack on the lining of affected joints to alleviate the debilitating symptoms, reduce inflammation and
slow the
progression of the disease.
To the degree that poor sleep promotes the development of Alzheimer's disease,
treatments for poor sleep or efforts to maintain healthy sleep patterns may help prevent or
slow the
progression of Alzheimer disease,» said Spira.
«Our findings suggest that restricting dietary intake of methionine and tryptophan might help
slow tumor
progression and improve
treatment outcomes,» says first author and OSUCCC — James researcher Kamalakannan Palanichamy, PhD, research assistant professor in Radiation Oncology.
«If we can identify infants with NPC early, we could direct these children to clinical trials, potentially beginning
treatment before they have begun to show symptoms of neurological damage, hopefully
slowing disease
progression and improving quality of life.»
However, Dr. Kissler's group discovered that reducing levels of the RGS1 protein did not
slow the
progression of the disease in mouse models, suggesting that it may not offer much potential for human
treatment.
Treatment with miglustat, an inhibitor of lipid synthesis that is approved outside the U.S. for treatment of NPC, has shown evidence of slowing disease pro
Treatment with miglustat, an inhibitor of lipid synthesis that is approved outside the U.S. for
treatment of NPC, has shown evidence of slowing disease pro
treatment of NPC, has shown evidence of
slowing disease
progression.
Current
treatments do not
slow the disease
progression and provide little relief from symptoms.
«There are currently no
treatments that are able to stop or
slow the
progression of Alzheimer's or protect the brain from the damage of the disease.
Christophe Benoist, M.D., professor of Microbiology and Immunobiology at Harvard Medical School, (who spoke on behalf of Diane Mathis, Ph.D., also a professor in the same department) discussed a molecule called I - BET that, when used as a
treatment in animals during pre-diabetes or in the early stages of clinical type 1 diabetes, seemed to
slow the
progression of the disease.
Huntington's is ultimately fatal, and there are no
treatments to stop or
slow its
progression.
They found that early phenformin
treatment causes increased survival and
slower tumor
progression in tumors lacking LKB1, but had no significant benefit for tumors with alterations in other lung cancer genes.
«Current
treatments can
slow these diseases»
progression, but they can't replace lost retinal cells.
Current
treatments for COPD can improve symptoms and reduce exacerbations but neither cure the disease nor
slow its
progression.
Many neurological disease symptoms worsen over time, making the primary goals of
treatment the control of symptoms and
slowing the
progression of the disease.
Thus, J147 is an exciting, new compound with strong potential to be an AD therapeutic by
slowing disease
progression through neuroprotection as well as providing rapid cognition benefits by reversing cognition deficits following short - term
treatment.
«
Treatment for HIV currently relies on drugs which target the viruses cell - cycle to
slow HIV replication (and the
progression to AIDS)(called antiretroviral therapy (ART).
«We are excited about this
treatment, because we think this has the potential to
slow the disease
progression,» said Steve Rose, chief research officer of the Foundation Fighting Blindness, a nonprofit that invested about $ 2 million in early animal testing of the
treatment, but is no longer directly involved.
There are currently no disease - modifying
treatments that have been shown to
slow the
progression or delay the onset of HD in humans; however, several compounds have demonstrated promise in animal models of HD.1 Robust and sensitive markers of disease
progression are required to assess their efficacy in humans.
Many of the
treatment options focus only on temporarily
slowing disease
progression and managing symptoms.
There is currently no cure for MS, only
treatments that can help
slow its
progression and manage symptoms — which is why the disease can use all the attention it can get.